AbolerIS Pharma secures €2.5 million from an investment consortium comprised of Turenne Santé/Sham Innovation Santé and Newton Biocapital.

Biotech Health services Pharma

Investments

04 November 2020

AbolerIS Pharma (company)

Biotech Health services Pharma

Total investments received (USD): 32.43m

Round value (USD): 2.97m

Round investors: Newton Biocapital Turenne Capital Partenaires

Industry: Biotech Health services Pharma

Biotech Health services Manufacturing

Investments 22 April 2021

Biotech Health services

Investments 14 April 2021

Biotech Health services Manufacturing

Investments 05 April 2021

Biotech Health services Pharma

Investments 03 April 2021

Biotech Health services

Investments 17 December 2020